Why the study?
The role of N-linked glycosylation in modulating the gating properties of CaV3.1-T-type Ca2+ channels was not fully understood.
N-glycosylation contributes to the regulation of gating properties and cell surface expression of the CaV3.1-T-type Ca2+ channel during cellular processing.
N-glycosylation modulates CaV3.1 gating in vitro; leaves open therapeutic relevance in cardiovascular disease pending in vivo data.
T-type channels are low-voltage-activated channels that play a role in the cardiovascular system particularly for pacemaker activity. Glycosylation is one of the most prevalent post-translational modifications in protein. Among various glycosylation types, the most common one is asparagine-linked ( N -linked) glycosylation. The aim of this study was to elucidate the roles of N -linked glycosylation for the gating properties of the Ca V 3.1-T-type Ca 2+ channel. N -linked glycosylation synthesis inhibitor tunicamycin causes a reduction of Ca V 3.1-T-type Ca 2+ channel current (Ca V 3.1- I Ca.T ) when applied for 12 h or longer. Tunicamycin (24 h) significantly shifted the activation curve to the depolarization potentials, whereas the steady-state inactivation curve was unaffected. Use-dependent inactivation of Ca V 3.1- I Ca.T was accelerated, and recovery from inactivation was prolonged by tunicamycin (24 h). Ca V 3.1- I Ca.T was insensitive to a glycosidase PNGase F when the channels were expressed on the plasma membrane. These findings suggest that N -glycosylation contributes not only to the cell surface expression of the Ca V 3.1-T-type Ca 2+ channel but to the regulation of the gating properties of the channel when the channel proteins were processed during the folding and trafficking steps in the cell.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: